Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cugno

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|June 29, 2005
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammationMassimo Cugno, Piergiuseppe Agostoni, Daniela Mari, et al.
Haematologica|November 9, 2014
A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activityRaffaella Rossio, Luca Andrea Lotta, Silvia Pontiggia, et al.
Plos One|June 10, 2015
Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic RiskMassimo Cugno, Alberto Tedeschi, Alessandro Borghi, et al.
British Journal of Haematology|June 17, 2004
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantationMassimo Cugno, Daniela Mari, Pier Luigi Meroni, et al.
Intensive Care Medicine|February 2, 2010
Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortalityTommaso Mauri, Giacomo Bellani, Nicolo' Patroniti, et al.
The American Journal of Cardiology|March 31, 2004
Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarctionPiera Angelica Merlini, Massimo Cugno, Marco L Rossi, et al.
Blood|March 6, 2023
Complement activation and renal dysfunction in patients with acquired thrombotic thrombocytopenic purpuraMassimo Cugno, Ilaria Mancini, Dario Consonni, et al.
Microorganisms|June 24, 2022
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 PatientsMassimo Cugno, Pier Luigi Meroni, Dario Consonni, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2020
Complement activation in patients with COVID-19: A novel therapeutic targetMassimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, et al.
Intensive Care Medicine|May 28, 2008
Tight glycemic control does not affect asymmetric-dimethylarginine in septic patientsGaetano Iapichino, Maura Albicini, Michele Umbrello, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|June 29, 2005
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammationMassimo Cugno, Piergiuseppe Agostoni, Daniela Mari, et al.
Haematologica|November 9, 2014
A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activityRaffaella Rossio, Luca Andrea Lotta, Silvia Pontiggia, et al.
Plos One|June 10, 2015
Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic RiskMassimo Cugno, Alberto Tedeschi, Alessandro Borghi, et al.
British Journal of Haematology|June 17, 2004
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantationMassimo Cugno, Daniela Mari, Pier Luigi Meroni, et al.
Intensive Care Medicine|February 2, 2010
Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortalityTommaso Mauri, Giacomo Bellani, Nicolo' Patroniti, et al.
The American Journal of Cardiology|March 31, 2004
Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarctionPiera Angelica Merlini, Massimo Cugno, Marco L Rossi, et al.
Blood|March 6, 2023
Complement activation and renal dysfunction in patients with acquired thrombotic thrombocytopenic purpuraMassimo Cugno, Ilaria Mancini, Dario Consonni, et al.
Microorganisms|June 24, 2022
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 PatientsMassimo Cugno, Pier Luigi Meroni, Dario Consonni, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2020
Complement activation in patients with COVID-19: A novel therapeutic targetMassimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, et al.
Intensive Care Medicine|May 28, 2008
Tight glycemic control does not affect asymmetric-dimethylarginine in septic patientsGaetano Iapichino, Maura Albicini, Michele Umbrello, et al.
Pageof 15